Chemfab Alkalis reported a consolidated net profit of ₹573.04 million for the quarter ended June 30, 2026, marking a 124% increase from ₹254.76 million in the corresponding period last year. The Chennai-based chemical manufacturer attributed this surge primarily to a significant deferred tax credit of ₹380.27 million, which offset operational headwinds including a 20.1% year-on-year revenue decline. This accounting adjustment significantly boosted headline earnings, masking underlying pressure in the pre-tax numbers where profit before tax fell 52.7% to ₹222.37 million.

The Board of Directors approved the unaudited standalone and consolidated financial results on July 29, 2026, following review by the Audit Committee. The results were supported by a limited review report from current statutory auditors Deloitte Haskins & Sells LLP. In compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Schedule III thereof and SEBI Master Circular no. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, the company published the results in Business Standard and Makkal Kural on July 31, 2026. Additionally, the company appointed M/s. M S K A & Associates LLP as its new statutory auditor for a five-year term, effective from the conclusion of the ensuing Annual General Meeting.

Financial Performance Overview

Despite the revenue contraction, Chemfab Alkalis delivered strong bottom-line growth due to non-operating factors. The total tax expense for the quarter was a credit of ₹350.67 million, contrasting with an expense of ₹215.22 million in the prior year period. This reversal was largely due to the re-measurement of Deferred Tax Liabilities after the company exercised the option for a lower tax rate under Section 200 of the Income Tax Act 2025 (erstwhile Section 115BAA).

Segmental Analysis

The company operates through two reportable segments: Chemicals and Related Products, and PVC-O Pipes. The Chemicals segment contributed ₹6,741.01 million to revenue, up from ₹5,283.89 million in Q1FY26, showing resilience in this core business area. In contrast, the PVC-O Pipes segment saw a sharp decline in revenue to ₹574.97 million from ₹3,870.20 million year-on-year.

Segment profitability mirrored this trend. The Chemicals segment reported a result before tax of ₹292.03 million, improving from a loss of ₹372.49 million in the previous year. Conversely, the PVC-O Pipes segment incurred a loss before tax of ₹57.23 million, compared to a profit of ₹863.16 million in Q1FY26. This divergence highlights the shifting dynamics within the group’s portfolio, with the chemicals business offsetting weaknesses in the piping division.

Operational Updates and Outlook

Management highlighted that ECU realisations in the Chlor-Alkali business improved sequentially from ₹39,100 per MT to ₹39,600 per MT during the quarter. A 10 MW Captive Hybrid Power supply commenced on May 25, 2026, expected to deliver long-term cost savings. During the quarter, the company invested ₹1,491 million towards sourcing power from the hybrid power plant under a power purchase agreement.

In the OPVC segment, demand remained impacted by the absence of fund flows under the Jal Jeevan Mission, with improvements expected from Q2FY27 onwards. The Bureau of Indian Standards (BIS) recently approved OPVC pipes for sewage applications, opening new market avenues. Direct manufacturing expenses included job work expenses of ₹364.47 million related to the production of aluminium chloride.

What the Numbers Show

The stark contrast between the decline in Profit Before Tax (-52.7%) and the surge in Net Profit (+124.9%) underscores the dominance of tax adjustments in driving the headline earnings for Q1FY27. While the operational performance improved in the Chemicals segment, the overall pre-tax profit fell significantly due to the collapse in the PVC-O Pipes segment’s contribution. Investors should note that the reported net profit growth is largely attributable to the one-time tax credit rather than sustained operational leverage or revenue expansion.

Promoters of Chemfab Alkalies have confirmed that no shares held by them or persons acting in concert were encumbered during the financial year 2025-26. The declarations were submitted to comply with Regulation 31(4) of the SEBI (Substantial Acquisition of Shares & Takeover) (Second Amendment) Regulation, 2019. The disclosures provide transparency regarding the holding status of key stakeholders.

Suresh Krishnamurthi Rao declared that he has not encumbered any shares of the company directly or indirectly during the financial year under review. Similarly, Dr. Rao Holdings Pte Limited confirmed that it has not encumbered any shares belonging to the company or persons acting in concert.

K. M. Padma also submitted a declaration stating that no shares held by her were encumbered during FY26. Team Hiitec Eqpt Private Limited provided an identical confirmation regarding its shareholding in the company.

Ramachandran N stated that he does not hold any shares in Chemfab Alkalies. Consequently, he declared that the provisions regarding encumbrance under Regulation 31(4) are not applicable to him, and there is no encumbrance on shares along with persons acting in concert.

The declarations were signed and dated April 01, 2026, in Chennai. The filings ensure regulatory compliance regarding the disclosure of share encumbrances by promoters.

Promoter Declarations